当前位置: X-MOL 学术J Law Biosci › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Covid-19, single-sourced diagnostic tests, and innovation policy.
Journal of Law and the Biosciences ( IF 2.5 ) Pub Date : 2020-07-07 , DOI: 10.1093/jlb/lsaa053
Chaarushena Deb , Osman Moneer , W Nicholson Price

At the heart of the United States, disastrous response to the Covid-19 pandemic is a failure of diagnostic testing. That something so fundamental to medical care could be so botched evokes incredulity. From primary care offices to critical care settings, every patient encounter begins with a diagnostic workup. Diagnostic testing tools are key parts of the physician’s toolkit, and confirmatory testing is essential. But in the greatest public health challenge of the 21st century, the failures of diagnostic testing have been laid entirely bare.

中文翻译:

Covid-19,单一来源的诊断测试和创新政策。

在美国的中心,对Covid-19大流行的灾难性反应是诊断测试的失败。对医疗保健如此重要的东西可能被如此卑鄙地唤起了怀疑。从基层医疗机构到重症监护室,每一次患者遭遇都始于诊断检查。诊断测试工具是医师工具包的关键部分,而确认测试至关重要。但是在21世纪最大的公共卫生挑战中,诊断测试的失败已完全暴露无遗。
更新日期:2020-09-05
down
wechat
bug